InvestorsHub Logo
Followers 1
Posts 160
Boards Moderated 0
Alias Born 10/17/2013

Re: sts66 post# 24635

Tuesday, 01/21/2014 12:35:03 PM

Tuesday, January 21, 2014 12:35:03 PM

Post# of 425915
If you remember from the Adcom, the FDA brought in the argument that the only reason to lower triglyceride levels in the Anchor range would be to lower CVE's. Therefore, the FDA decided that the Anchor indication, although not explicitly stating so, would imply this reduction...

The FDA screwed Amarin, period!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News